Trivascular Technologies Company Profile (NASDAQ:TRIV)

About Trivascular Technologies (NASDAQ:TRIV)

Trivascular Technologies logoTrivascular Technologies, Inc. is a medical device company developing and commercializing technologies to advance minimally invasive treatment of abdominal aortic aneurysms (AAA). The Ovation System, the Company's solution for the treatment of AAA through minimally invasive endovascular aortic repair, or EVAR, is a stent graft platform, providing an alternative to conventional devices. It is designed to specifically address many of the limitations associated with conventional EVAR devices and expand the pool of patients eligible for EVAR. The Company is developing Ovation iX iliac limbs for use with both its Ovation Prime and its Ovation iX and Alto aortic bodies, which are in development. Trivascular is developing Ovation iX aortic bodies for use with both its Ovation Prime and its Ovation iX iliac limbs. The Company is developing an aortic body that together with the iliac limbs makes up the Ovation Alto stent graft.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Symbol: NASDAQ:TRIV
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $6.49
  • 200 Day Moving Avg: $6.07
  • 52 Week Range: $3.98 - $11.49
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.16
  • P/E Growth: 0.00
Misc:
  • Average Volume: 17,155 shs.
 

Frequently Asked Questions for Trivascular Technologies (NASDAQ:TRIV)

What is Trivascular Technologies' stock symbol?

Trivascular Technologies trades on the NASDAQ under the ticker symbol "TRIV."

How were Trivascular Technologies' earnings last quarter?

Trivascular Technologies Inc (NASDAQ:TRIV) announced its quarterly earnings results on Monday, November, 9th. The company reported ($0.66) earnings per share for the quarter, topping analysts' consensus estimates of ($0.71) by $0.05. The company earned $9.50 million during the quarter, compared to analyst estimates of $9.28 million. Trivascular Technologies's quarterly revenue was up 20.3% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.69) EPS. View Trivascular Technologies' Earnings History.

Who are some of Trivascular Technologies' key competitors?

How do I buy Trivascular Technologies stock?

Shares of Trivascular Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Trivascular Technologies' stock price today?

One share of Trivascular Technologies stock can currently be purchased for approximately $5.87.


MarketBeat Community Rating for Trivascular Technologies (NASDAQ TRIV)
Community Ranking:  3.9 out of 5 (  )
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  12 (Vote Underperform)
Total Votes:  54
MarketBeat's community ratings are surveys of what our community members think about Trivascular Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Trivascular Technologies (NASDAQ:TRIV) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Trivascular Technologies (NASDAQ:TRIV)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/23/2015BTIG ResearchDowngradeBuy -> Neutral$8.00N/AView Rating Details
8/10/2015Credit Suisse Group AGReiterated RatingHold$10.00 -> $8.00N/AView Rating Details
8/5/2015Canaccord GenuityReiterated RatingBuy$13.00N/AView Rating Details
7/9/2015Bank of America CorpInitiated CoverageNeutral -> BuyN/AView Rating Details
(Data available from 5/29/2015 forward)

Earnings

Earnings History for Trivascular Technologies (NASDAQ:TRIV)
Earnings by Quarter for Trivascular Technologies (NASDAQ:TRIV)
Earnings History by Quarter for Trivascular Technologies (NASDAQ:TRIV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2015Q3($0.71)($0.66)$9.28 million$9.50 millionViewN/AView Earnings Details
8/4/2015Q215($0.73)($0.73)$8.78 million$9.70 millionViewN/AView Earnings Details
5/5/2015Q115($0.68)($0.77)$8.48 million$9.00 millionViewListenView Earnings Details
3/3/2015Q414($0.65)($0.72)$9.54 million$9.10 millionViewListenView Earnings Details
11/10/2014Q314($0.63)($0.69)$7.90 million$7.88 millionViewN/AView Earnings Details
8/6/2014Q214($0.66)($0.87)$7.54 million$7.80 millionViewN/AView Earnings Details
5/14/2014Q1 14($1.10)($1.17)$6.90 million$7.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Trivascular Technologies (NASDAQ:TRIV)
Current Year EPS Consensus Estimate: $-2.84 EPS
Next Year EPS Consensus Estimate: $-2.72 EPS

Dividends

Dividend History for Trivascular Technologies (NASDAQ:TRIV)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Trivascular Technologies (NASDAQ:TRIV)
Insider Trades by Quarter for Trivascular Technologies (NASDAQ:TRIV)
Insider Trades by Quarter for Trivascular Technologies (NASDAQ:TRIV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/22/2014Douglas A RoederDirectorBuy833,333$12.00$9,999,996.00View SEC Filing  
4/22/2014Enterprise Associates 12 NewMajor ShareholderBuy583,333$12.00$6,999,996.00View SEC Filing  
4/22/2014James E FlynnInsiderBuy1,065,000$12.01$12,790,650.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Trivascular Technologies (NASDAQ:TRIV)
Latest Headlines for Trivascular Technologies (NASDAQ:TRIV)
Source:
DateHeadline
biz.yahoo.com logoTRIVASCULAR TECHNOLOGIES, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acqu
biz.yahoo.com - February 3 at 5:23 PM
biz.yahoo.com logoTriVascular Technologies, Inc. (TRIV)
biz.yahoo.com - January 17 at 7:47 PM
finance.yahoo.com logoTRIVASCULAR TECHNOLOGIES, INC. Financials
finance.yahoo.com - December 8 at 1:17 PM
biz.yahoo.com logoTRIVASCULAR TECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
biz.yahoo.com - November 9 at 4:21 PM
biz.yahoo.com logoQ3 2015 TriVascular Technologies Inc Earnings Release - After Market Close
biz.yahoo.com - November 9 at 7:07 AM
finance.yahoo.com logoPreliminary Results of the LIFE Study Presented at VIVA 2015
finance.yahoo.com - November 3 at 12:45 PM
finance.yahoo.com logoFour-Year Results From Global Ovation Pivotal Trial Presented at VIVA 2015
finance.yahoo.com - November 3 at 12:30 PM
finance.yahoo.com logoTRIV SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of TriVascular Technologies, Inc. Regarding the Sale of the Company to Endologix, Inc.
finance.yahoo.com - November 2 at 12:01 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of TriVascular Technologies, Inc. -TRIV
finance.yahoo.com - October 30 at 9:45 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of TriVascular Technologies, Inc. of an Investigation Concerning the Fairness of the Sale of the Company to Endologix, Inc.
finance.yahoo.com - October 30 at 11:04 AM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of TriVascular Technologies, Inc. And Encourages Investors To Contact The Firm For Additional Information
finance.yahoo.com - October 29 at 5:25 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of TriVascular Technologies, Inc. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to Endologix, Inc. - TRIV
finance.yahoo.com - October 29 at 2:29 PM

Social

Chart

Trivascular Technologies (TRIV) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by MarketBeat.com Staff